BIOCRYST PHARMACEUTICALS, INC.

Calendar BioCryst Pharmaceuticals, Inc.

Stocks

BCRX

US09058V1035

Biotechnology & Medical Research

Market Closed - Nasdaq 20:00:00 30/10/2026 GMT			5-day change	1st Jan Change
8.470 ^USD	-0.59%		+8.87%	+8.59%

10-29	Biocryst Pharmaceuticals, Inc. Presents New Data for Orladeyo and Navenibart At the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting	CI
10-21	BioCryst Pharmaceuticals Pellet Form of Hereditary Angioedema Treatment Approved by US FDA	MT

Chart calendar BioCryst Pharmaceuticals, Inc.

1c.IfBxdCiRQ0ZdT2BjHnRphL63X3ZzLp9WGH5UXqbjKgw.RpQdOln5N3QWA1Y5awYb4ozOCD0VZcwXbQoaP5OgcjV1xjAZHuV1PAQ3IQ~6bfa17cf50eb64a553379c2d6eeff50d

Upcoming events on BioCryst Pharmaceuticals, Inc.

04/11/2026	Earnings release - Q3 2026
04/11/2026	Earnings presentation	13:30

Past events on BioCryst Pharmaceuticals, Inc.

05/08/2026	Earnings release - Q2 2026
05/08/2026	Earnings presentation	13:30
11/06/2026	Annual General Meeting	15:00
06/05/2026	Earnings presentation	13:30
06/05/2026	Earnings release - Q1 2026
26/02/2026	Earnings release - Q4 2025
26/02/2026	Earnings presentation	13:30
03/11/2025	Earnings release - Q3 2025
03/11/2025	Earnings presentation	13:30

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	331 328 0.92%	451 449 0.32%	875 620 41.06%	710	736	830
EBITDA Million USD	Released Forecast Spread	-102 -101 -1%	-1,30 18,8 -106.89%	342 96,0 256.65%	-174	196	282
EBIT Million USD	Released Forecast Spread	-104 -83,5 -24.27%	-2,54 12,6 -120.24%	341 121 180.9%	-508	247	316
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-226 -192 -17.8%	-87,0 -73,6 -18.11%	267 30,5 776.13%	-582	184	279
Net income Million USD	Released Forecast Spread	-227 -193 -17.14%	-88,9 -74,7 -19.06%	264 32,1 721.69%	-582	175	249
EPS USD	Released Forecast Spread	-1,18 -1,06 -11.81%	-0,43 -0,35 -21.82%	1,21 0,14 764.29%	-2,31	0,68	0,78
Announcement Date		26/02/24	24/02/25	26/02/26	-

Quarterly results

Fiscal Period	June	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4	2028 Q1	2028 Q2
Net sales Million USD	Released Forecast Spread	132 130 1.14%	146 128 13.89%	163 150 9.03%	159 163 -2.2%	407 151 168.67%	156 151 3.5%	218 183 19.05%	166	170	167	186	191	341	168	187
EBITDA Million USD	Released Forecast Spread	-4,20 9,00 -146.66%	21,6 7,00 207.97%	30,1 22,3 35.17%	29,9 43,0 -30.4%		-701 10,7 -6648.28%	99,0 24,6 302.62%	38,7	26,0
EBIT Million USD	Released Forecast Spread	-4,51 10,2 -144.36%	21,2 7,26 192.25%	29,8 25,3 17.68%	29,6 30,9 -4.26%	260 23,2 1022.23%	-702 19,3 -3734.68%	98,5 45,3 117.4%	44,9	49,0	41,2	65,8	80,0	85,1
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-26,0 -12,9 -102.17%	0,76 -14,7 105.16%	6,49 5,75 12.8%	12,1 15,1 -19.62%	248 10,5 2266.44%	-721 7,16 -10166.69%	79,5 25,4 213.13%	22,4	25,4	31,1	48,4	62,0	66,8
Net income Million USD	Released Forecast Spread	-26,8 -12,7 -111.05%	0,03 -15,0 100.21%	5,09 3,97 27.94%	12,9 9,48 36.03%	246 11,6 2015.9%	-722 12,1 -6042.05%	78,4 31,5 149.2%	22,8	28,6	29,4	42,9	53,2	56,0	28,4	28,1
EPS USD	Released Forecast Spread	-0,13 -0,05 -137.49%	0,00 -0,06 -	0,02 0,02 18.34%	0,06 0,05 14.7%	1,12 0,05 2205.95%	-2,98 0,05 -5830.77%	0,30 0,12 152.23%	0,08	0,11	0,13	0,20	0,22	0,23	0,11	0,11
Announcement Date		24/02/25	05/05/25	04/08/25	03/11/25	26/02/26	06/05/26	05/08/26	-	-	-	-	-	-	-	-

Upcoming sector events for BioCryst Pharmaceuticals, Inc.

Today	DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.	Earnings release - Q3 2026
Today	SINOCELLTECH GROUP LIMITED	Earnings release - Q3 2026
Today	CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD.	Earnings release - Q3 2026
02/11/2026	TRAVERE THERAPEUTICS, INC.	Earnings release - Q3 2026
02/11/2026	TRAVERE THERAPEUTICS, INC.	Earnings presentation	21:30
02/11/2026	RECURSION PHARMACEUTICALS, INC.	Earnings release - Q3 2026
03/11/2026	BIONTECH SE	Earnings presentation	13:00
03/11/2026	BIONTECH SE	Earnings release - Q3 2026
03/11/2026	MADRIGAL PHARMACEUTICALS, INC.	Earnings presentation	13:00
03/11/2026	MADRIGAL PHARMACEUTICALS, INC.	Earnings release - Q3 2026

Past sector events for BioCryst Pharmaceuticals, Inc.

30/10/2026	INVENTISBIO CO., LIMITED	Earnings release - Q3 2026
30/10/2026	LONGBIO PHARMA (SUZHOU) CO., LTD.	Extraordinary General Meeting	08:00
29/10/2026	INSMED INCORPORATED	Earnings presentation	12:00
29/10/2026	INSMED INCORPORATED	Earnings release - Q3 2026
29/10/2026	EXELIXIS, INC.	Earnings presentation	21:00
29/10/2026	EXELIXIS, INC.	Earnings release - Q3 2026
29/10/2026	REMEGEN CO., LTD.	Board of Directors Meeting
29/10/2026	REMEGEN CO., LTD.	Earnings release - Q3 2026	08:00
29/10/2026	HITGEN INC.	Earnings release - Q3 2026
29/10/2026	IDORSIA LTD	Earnings release - Q3 2026

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BioCryst Pharmaceuticals, Inc.

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - BioCryst Pharmaceuticals, Inc.

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BioCryst Pharmaceuticals, Inc.

Stock Market
Stocks
BCRX Stock
Calendar BioCryst Pharmaceuticals, Inc.

As early as today, start finding the best investment opportunities!